Placeholder Image

Subtitles section Play video

  • Eye conditions are on the rise. From cataracts to near-

  • sightedness and macular degenerationmillions of

  • people worldwide suffer from poor vision.

  • Reading fine print is almost impossible. You have to hold

  • the book up to your face.

  • Young people are increasingly affected -- around 217 million

  • people are visually impaired, and 36 million

  • are blind worldwide.

  • Our sense of sight plays a vital role in our lives, and

  • things are very difficult for people who are blind.

  • Modern surgical techniques are less invasive

  • and can help restore eyesight.

  • It's a quantum leap — a minor revolution.

  • From stem cell therapy to laser surgerynew

  • treatments are giving patients hope.

  • This residential development in the city of Mainz, Germany,

  • is home to Lilli, her brother Max, and their parents. 13-

  • year-old Lilli is an ordinary teenager - she goes to dance

  • class twice a week, and she likes to chat with her friends.

  • Lilli has been near-sighted since the fourth grade. She

  • has minus 4 diopters in her right eye,

  • minus 0-point-5 in her left one.

  • When Lilli takes off her glasses, the world looks like this

  • even nearby objects appear blurred. And her

  • eyesight is continuing to deteriorate.

  • I see things best when they are very close, but it keeps

  • getting worse. When I take off my glasses, even my hand

  • looks blurry. Anything further away is even blurrier.

  • Nearsightedness - or myopia - is the result of the shape of

  • the eye. Normally rays of light entering the eye are refracted

  • so that they focus on the retina at the back of the eye.

  • When the eyeball is too long or the cornea too curved,

  • the light focuses at a point in front of the retina.

  • Objects that are further away appear blurred.

  • Our eyes are designed for distance vision. Spending a

  • lot of time looking at nearby objects puts strain on our

  • eyes. Our eyes then gradually deform so that we can see

  • nearby objects more easily. But then we end up not being

  • able to see objects at a distance as well. That's

  • what's called being nearsighted.

  • Myopia is partly hereditary. Lilli's parents

  • are also nearsighted.

  • Lilli has an appointment at the Eye Clinic in Mainz for a

  • thorough examination.

  • Norbert Pfeiffer heads the eye clinic, and is a specialist in

  • near-sightedness.

  • First comes the exam with the slit lamp.

  • So put your chin on the chin rest.

  • He first examines the ocular fundus and optic nerve in both

  • eyes. Near-sighted people should get a vision exam at

  • least once a year. Myopia can promote the development of

  • other serious eye disorders. It increases the risk of retinal

  • detachment and cataracts.

  • Lilli is nearsighted, at minus 4 to 5 diopters. That's fairly

  • nearsighted - not as much as some, but it's quite a lot. She

  • started out with a quarter of a diopter, when she was

  • about ten. That tends to increase with age,

  • until maybe age 18 or 20.

  • For Norbert Pfeiffer, Lilli is an example of how

  • nearsightedness is on the rise. He's investigating the cause of

  • this increase in a large-scale German study involving

  • 15,000 patients. The study has been underway for 12 years.

  • The longer you go to school, the more near-sighted you

  • become. For every year you go to school, you get a bit

  • more near-sighted. And that goes for university degrees

  • the longer you study, the more nearsighted you

  • become. So nearsightedness has a behavioral component.

  • So myopia isn't just hereditary -- our lifestyle plays a role.

  • Near-sightedness is linked to educational levels

  • and is on the rise worldwide.

  • In Asia, even more young people are nearsighted. In

  • some countries, up to 80 or 90 percent. We think one

  • factor might be the age at which children start school. In

  • some Asian countries, they start school when

  • they're just three or four years old.

  • In Taiwan, for example, myopia has reached epidemic

  • proportions. Up to 90 percent of schoolchildren in major

  • cities are nearsighted. Schools and universities are pressure

  • cauldrons. The workload is heavy - even more than in

  • Europe. Long hours of studying lead to more near-

  • sightedness. What many don't realize is that if myopia

  • remains untreated, it can even lead to blindness.

  • Russ Khan shrugged off his vision problems for years. A

  • software engineer, he was working on a new program

  • when he suffered a retinal detachment. He underwent

  • 12 surgeries, but nothing helped. Russ Khan is now

  • blind. At one point, he contemplated suicide.

  • I can hear. I can move. They're always going to be

  • there for me. That's the love. And because of the family

  • bondings. They made me realize that perhaps if I'm

  • settled down more myself, I can do something. I can still

  • do something for myself and others.

  • Russ Khan now goes to schools to tell his story and

  • raise awareness about near-sightedness.

  • In the classroom, he tries to connect with

  • the children on a personal level.

  • Every half hour, we let our eyes have a break. How long?

  • Ten minutes, they reply.

  • And lastly, how long should you play outside every day?

  • Two hours!

  • The children are supposed to give their eyes a break from

  • schoolwork. But long hours hitting the books is ingrained

  • in Asian culture. It's an uphill battle. The WHO estimates

  • that half the world's population will be shortsighted

  • within 30 years. But simple measures

  • could make a difference.

  • The most important thing is to send children outside into

  • the sunlight for two hours every day. We know this is

  • the best way to prevent nearsightedness.

  • An instrument called a luxmeter is

  • used to measure light intensity.

  • You'd probably say there's plenty of light in this office,

  • enough to work by. But the meter is showing 102.5 lux.

  • That's not much light. The light is much brighter outside.

  • Even bright lamps are no substitute for daylight. Eyes

  • need sunlightthe chance to view objects at a distance.

  • Outside, the light intensity is 100 times higher:

  • I took the meter outside. Even though it's cloudy, we're

  • seeing 13,600 lux. That's much higher. If it were sunny

  • out, it would be even higher than that.

  • Bright sunlight can be up to 100,000 lux or more. It may

  • seem trivial, but daylight works wonders

  • against nearsightedness.

  • Back at the clinic, Lilli is undergoing another a vision

  • test. She's supposed to read the numbers off the chart.

  • She's asked if she can read the largest number.

  • Even the largest number is blurred.

  • Norbert Pfeiffer will continue monitoring Lilli's vision and

  • making sure she gets enough sunlight. It's the only way to

  • treat her nearsightedness and preserve her vision.

  • An eye clinic in Cologne, Germany, specializes

  • in other vision problems.

  • Alfred Remmert is 60 years old. He lives an hour away and

  • comes here for treatment. Remmert runs a company

  • with over two thousand employees and often travels

  • abroad. His vision has been deteriorating

  • for some time now.

  • This is what it looks like out the window. This is what

  • Alfred Remmert sees. And it's getting worse.

  • It's all kind of foggy. Blurry and foggy. Right now I'm still

  • coping but ordinary activities are getting more difficult.

  • Alfred Remmert has come here for a consultation with

  • Claus Cursiefen. He's chief physician at the clinic and a

  • leading expert in corneal disorders. His exam shows

  • that Alfred Remmert is a good candidate for surgery.

  • The lens and cornea are clouded. So two layers of the

  • eye are clouded. In one surgical procedure, we'll try

  • to eliminate both sources of this clouded vision. We'll

  • replace the lens, and transplant the

  • inner layer of the cornea.

  • The transparent cornea is part of the outer casing of the eye,

  • and serves as a kind of windshield. Behind it, the iris

  • opens and closes to control the amount of light entering

  • the eye. The lens focuses the incoming light to create a

  • sharp image on the retina. The optic nerve then transmits

  • that information to the brain.

  • Two hours later, the surgery is underway. Claus Cursiefen is

  • preparing the corneal transplant. The clinic has its

  • own eye bank - with corneas from organ donations. The

  • cornea does not have a direct blood supply. For that reason,

  • it can be removed up to 72 hours after death.

  • Claus Cursiefen carefully removes the edges of the cornea.

  • The blue contrast agent helps him guide

  • the delicate incisions.

  • The cornea is only a few thousandths of a millimeter

  • thick. Using a precision instrument, he removes the

  • inner layer of the cornea.

  • The delicate tissue is rolled up, and then placed on injector.

  • The instrument will later help him position the

  • cornea in the patient's eye.

  • The patient is wheeled into the operating room. Alfred

  • Remmert already under general anesthesia.

  • The eyelids are held open with retractors.

  • With three tiny incisions, the diseased inner layer

  • of the cornea is removed.

  • This is the inner, clouded layer of the cornea, which is

  • selectively removed. It is about ten-thousandth of a

  • millimeter thick. We only remove the diseased layer

  • here and can leave the rest of the cornea in place.

  • That speeds up the healing process. Just a few years ago,

  • the entire cornea would have been transplanted.

  • Then the injector is inserted into the eye and the thin

  • corneal layer is unraveled.

  • The blue-colored structure in front of the eye is the

  • transplant. Now we have to put it in the proper position.

  • Now we fill the eye with a gas. The gas bubble presses the

  • transplant firmly onto the back of the cornea. We don't

  • sew it onit's held in place by this gas bubble.

  • The gas bubble pushes the transplant onto the cornea. In

  • order for it to attach properly, the patient will need to lie on

  • his back quietly for several days.

  • Everything goes smoothly and the surgery is a success.

  • Sigrid Roters helps manage the eye bank at the clinic.

  • Today she retrieved a donor eye from the pathology

  • department. The clinic in Cologne opened its

  • eye bank in 2000.

  • Sigrid Roters carefully examines the eye for any sign

  • of disease. Then she detaches the cornea bit by bit. Human

  • corneas are still used in transplants, but artificial

  • corneas are now under development.

  • The doctor places the cornea in a nutrient medium and

  • maintains the incubator at the perfect temperature, ready

  • for the next transplant surgery. Demand is high.

  • 6,000 corneal transplants take place each year in

  • Germany and there are another 6,000 recipients on

  • the waiting list. Of course, we would like to have more

  • donors to meet this demand.

  • Five weeks after the procedure, Alfred Remmert is

  • back at the Cologne clinic for a checkup. Since corneas don't

  • have their own blood vessels, they're rarely rejected by the

  • recipient's immune system

  • unlike with donor hearts, for example.

  • But he did have some difficulties at first.

  • I'm doing well now but the first 14 days were hard. My

  • eye was very sensitive, I could hardly open it. My eye

  • was watering and my vision was blurred. Then my other

  • eye started watering, too, and felt the strain. But about

  • ten days ago, things got a lot better.

  • The surgery was a complete success, and the healing

  • process is going well. Before the surgery, Mr. Remmert's

  • vision was down to about 40 percent. Now it's at 90

  • percent and it will continue to improve.

  • Alfred Remmert's vision in his right eye is

  • almost normal again.

  • The University Hospital in Bonn, Germany, focuses on

  • one of the most common eye conditions in the Western

  • world: age-related macular degeneration, or AMD.

  • Karin Krause-Zillich suffers from what is called wet AMD.

  • This is how healthy eyes see the world. This is what Karin

  • sees. She is almost blind in her left eye.

  • Wet AMD is less common than the dry form, and it

  • progresses more quickly. At first Karin Krause-Zillich barely

  • noticed the symptoms.

  • When I was doing my make-up and would close one eye

  • to do the other one, I thought, something's not right. There's

  • a dark spot that shouldn't be there. Then I saw my

  • ophthalmologist. He did several tests

  • and I got a diagnosis.

  • The macula is a small area in the retina at the back of the

  • eye. It's where our vision is the sharpest and it contains

  • most of the light sensing cells. In AMD, blood vessels leak

  • fluid or blood into the macula. That leads to swelling, and

  • damages the photoreceptors.

  • Frank Holz specializes in the treatment of macular

  • degeneration. Although AMD cannot be cured, its

  • progression can be slowed.

  • The dangerous thing about this condition is that it

  • irreversibly destroys the photoreceptors located in the

  • center of the retina, in the macula, where our vision is

  • the sharpest. That's what allows us to read, recognize

  • faces, and driveso many everyday activities rely on it.

  • Once the macula is destroyed, people find themselves

  • with a serious disability.

  • Karin Krause-Zillich comes in for a check-up every four

  • weeks. Left untreated, the disease progresses very quickly.

  • These green lines indicate where a cross-section of the

  • retina is being displayed. This allows us to examine the

  • structure of the retinal layers, and see where

  • there might be fluid.

  • Today the news isn't good. The scans show a small gray

  • sickle on the retina. Karin Krause-Zillich will need

  • another injection of the drug that's used to

  • treat the condition.

  • The preparations are complex. Eyes are delicate organs.

  • Everything needs to be sterile to ensure that bacteria won't

  • enter the retina.

  • The drug is injected directly into the eye. The drugs inhibit

  • a growth factor that promotes the formation of

  • new blood vessels.

  • The procedure itself takes just a few seconds.

  • It's like a little prick on your finger. It's over in a moment

  • and that's it. I'm grateful this treatment exists.

  • She's responding to the treatment quite well. But

  • we'll have to keep repeating it. This is a chronic condition

  • that won't go away or get better.

  • Not all patients manage as well as Karin Krause-Zillich.

  • Many patients discontinue treatment, and the drugs

  • don't work for everyone.

  • At the Sulzbach eye clinic near Saarbrucken, doctors are

  • investigating new therapies. Boris Stanzel is a

  • leader in the field.

  • He specializes in retinal surgery and stem-cell research

  • and is currently running a major clinical study on AMD.

  • Ingrid Moser is one of 150 patients who are taking part in

  • the pilot phase of a new stem-cell therapy. She was also

  • receiving the injections, but they stopped working. Using

  • this scanner, Boris Stanzel checks to see how quickly the

  • disease is progressing.

  • The macula is in the middle, and here's the optic nerve.

  • This black area around what was the macula is where the

  • cells have died, and it's getting bigger.

  • The disease is very advanced. Ingrid Moser's vision is only 5

  • percent of normal in her right eye and 10 percent

  • in the left one.

  • The new therapy aims to reprogram stems cells

  • extracted from the participants' blood. Then the

  • dead retinal cells will be replaced with the

  • reprogrammed ones.

  • We're hoping to replace cells in this layer here. Right here

  • it's still healthy. And you can see right here, they're missing.

  • If we can get new cells to take root in this area, then we

  • might be able to revive the outer portion of the retina,

  • which is still in relatively good shape.

  • Another benefit of this kind of stem-cell therapy is that it

  • doesn't involve any potential ethical concerns.

  • We don't have to use embryonic stem cells. We

  • extract the stem cells from the patient's own blood, in

  • much the same way that you do in a bone marrow

  • donation. Then we convert them into the proper cells in

  • the laboratory, and implant them back into

  • the patient again.

  • The IBMT Fraunhofer Institute is located just a short distance

  • from the clinic, and is collaborating in the

  • development of the new therapy.

  • Boris Stanzel is meeting with Hagen von Briesen, director of

  • the stem cell laboratory. The two scientists will check on

  • how the reprogramming of the eye cells is coming along.

  • The researchers here work with cell cultures. First they

  • reprogram the blood cells, turning back the clock to

  • return them to an undifferentiated state. Next

  • they multiply the cells, and then reprogram them. Those

  • will become new tissue cells - including retinal cells.

  • The new retinal cells can be seen under a microscope.

  • Reprogramming them is complex.

  • We have to treat these cells with specific biological factors.

  • That allows you to return the cells to their original state.

  • It's quite an amazing accomplishment, something

  • we never dreamed we could do. 20 years ago, it would

  • have been unthinkable.

  • The researchers then preserve the new retinal cells. To store

  • them long term, they'll be frozen in a container filled

  • with liquid nitrogen at a

  • temperature of minus 140 degrees Celsius.

  • Each sample is scanned and labeled for each patient. The

  • container is then placed in the stem cell bank.

  • With 20,000 samples so far, and 15 different partners in

  • industry and medicine, this stem cell bank is unique in

  • Europe. It's a promising project, and researchers hope

  • that it might one day provide new therapies for eye

  • conditions that today are untreatable.

  • This therapy won't be available any time soon. But

  • we've been able to show that the therapy would work in

  • principle. Now we'll have to get through the approval

  • process, which is time consuming and involves a lot

  • of regulatory steps. It's a process that takes several

  • years here in Germany.

  • The researchers have laid the groundwork for a

  • revolutionary new therapy - using reprogrammed stem

  • cells to restore vision. In a few years, this might be a major

  • advance in preventing AMD-related blindness.

  • At the Medical University of Vienna, scientists are also

  • staking out new territory. Ursula Schmidt-Erfurth is

  • director of the department of ophthalmology and optometry,

  • which is investigating new diagnostic procedures

  • for eye conditions.

  • Our eyes are our window to the world. But we can also

  • look into the eyes, into what's happening inside

  • them. We can look into the clear cornea and the clear

  • lens, which we also call the clear media.

  • Ophthalmologists can look inside the eye and laser

  • scanners can also make the surface of the retina visible.

  • Laser scanners can also peer into the retina's deeper layers,

  • and create a highly detailed image. With 40,000 separate

  • scans, the device can examine the retina in 3D.

  • Once the laser scanner creates an image of the patient's eye,

  • the high-resolution images are analyzed with the help of

  • artificial intelligence.

  • The system, or the computer, basically works just like the

  • human brain. It learns and gathers experience, and gets

  • smarter. You can feed the computer an infinite quantity

  • of data from an infinite number of patients and an

  • infinite number of medical conditions. And the system

  • learns to how draw the correct conclusions.

  • Ingeborg Nowak suffers from age-related macular

  • degeneration. The 3D scan of her left eye was compared to

  • the images of thousands of

  • other patients in the database to detect cell changes.

  • The new diagnostic procedure identified tiny defects

  • developing on her retina in time for them to be treated.

  • If that exam and the follow-up treatment had been

  • delayed, I probably would have lost the vision

  • in my left eye.

  • In the data laboratory, IT experts are fine-tuning the

  • algorithms that will be used to generate an accurate

  • diagnosis and devise personalized

  • treatment regimens.

  • The algorithm can analyze millions of pixels very quickly.

  • Then it tells us whether the disease is progressing,

  • whether the current treatment is working, or

  • whether a new therapy might be more effective.

  • The algorithms are so effective that the system will

  • soon be used to diagnose other health conditions.

  • We think that in the near future, this system will allow

  • us to reliably identify signs of cardiovascular disease at an

  • early stage, and help prevent heart attacks in

  • high-risk patients.

  • Our retina is like a window to our blood vessels -- tiny

  • changes in our vascular system can be identified in

  • our eyes far earlier than elsewhere in the body. One

  • day, eye scanners might be used as a kind of early

  • warning system.

  • Karin Schultz-Igast is about to undergo surgery. She suffers

  • from cataracts - the lenses of her eyes have grown opaque.

  • Cataracts gradually grow

  • worse and can lead to blindness.

  • This is normal vision, and this is how Karin Schultz sees the

  • world. The condition has a major impact on her daily life.

  • For example, she can no longer drive.

  • Stars at night look like little flowers, for example. They

  • have a halo of little dots surrounding them.

  • Cataracts grow more common as we age. 90 percent of

  • people over the age of 65 will develop cataracts. Other

  • symptoms include difficulty with bright light, and difficulty

  • seeing at night.

  • Karin Schultz's vision has deteriorated to the point

  • where she's decided to have surgery at the

  • Augsburg eye clinic.

  • A preliminary exam will show how far the cataracts have

  • progressed, and whether she's suffering from any

  • other eye disorders.

  • Three different tests are carried out.

  • The optician records the results.

  • This is the front surface of the cornea, the back surface, and

  • its thickness ?. Here's the cornea, the anterior chamber

  • depth, and the clouded lens, and here we have key data

  • about the cornea.

  • Felix Rombold explains the procedure. Doctors still don't

  • know exactly what causes cataracts. They believe it's

  • part of the natural aging process, which also

  • affects our eyes.

  • For Felix Rombold, this is a routine procedure. He carries

  • out 20 to 30 cataract surgeries a day.

  • The clouded lens is replaced with an artificial one that

  • remains in place for the rest of the patient's life. This

  • special artificial lens also reduces corneal curvature. It

  • provides sharp distance vision, with a lower range of

  • about 60 to 80 centimeters away.

  • Felix Rombold puts the femtosecond laser into

  • position. This technology enables tissue to be cut with

  • high speed and precision. The device costs 500,000 euros.

  • The doctor positions the eye and cuts a circular opening

  • into the anterior capsule with the laser.

  • The laser created a perfect opening in the anterior lens

  • capsule. I'm flushing the lens with saline solution now so I

  • can move it.

  • The lens remains in its capsule. With the help of the liquid,

  • the doctor can move the lens and gently remove it.

  • Now I'll to use the ultrasound device. The eye

  • remains stable.

  • The laser dissolves the nucleus of the lens, which

  • is then extracted.

  • Now we've completely removed the lens. What

  • remains is the patient's own lens capsule. The artificial

  • lens is inserted into it.

  • It's high-precision work. Cataract surgery has been

  • transformed over the past 10 years.

  • The incisions are getting thinner and thinner. Today

  • they're just two, or two and a half millimeters thick. That

  • means we're intervening in the eye, touching and moving

  • the eye, far less. And that in turn speeds up healing and

  • considerably reduces the risk. The rehabilitation

  • phase is much shorter.

  • Around 700,000 of these outpatient procedures are

  • carried out in Germany every year. Complications such as

  • bleeding inside the eye or infections are rare.

  • About 10,000 kilometers to the south, a convoy is making

  • its way through Rwanda in eastern Africa.

  • The ophthalmologist Silvain El-Khoury is on board. He and his

  • team are traveling from the Kabgayi Eye Clinic to an

  • outlying area. The doctors make this journey

  • only once a year.

  • This is a mobile clinic. We take all our equipment with

  • usour surgical microscope, our instrumentsand go to

  • remote regions to carry out surgeries. We mostly treat

  • cataracts, which sometimes even lead to blindness.

  • The team has reached its destination, an outpost an

  • hour's drive from the clinic.

  • The patients are already waiting. Silvain El-Khoury's

  • work is funded by the German CBM aid organization.

  • The outpost is a lifeline for people who can't make the

  • journey to the city.

  • Philamene Nyirami has been blind for five years now. She

  • had to move in with her daughter because she could

  • no longer manage on her own.

  • The exam shows that she has cataracts, and the disease as

  • progressed to an advanced stage.

  • She can only see shadows against the light. Light and

  • shadows, basically, maybe the outlines of shapes.

  • But definitely not faces.

  • Philamene Nyirami was unable to make the trip to the

  • city to see a doctor.

  • It will depend on the doctors here and God! I have

  • confidence in doctors who are always fighting for our

  • good health. I can't treat myself, after all. I have to

  • have hope in them.

  • Silvain El-Khoury decides to carry out the surgery on the

  • left eye that same day. The next day, he'll operate

  • on the right eye.

  • One of the rooms is converted into an operating room.

  • Everything is adapted to the conditions in Africa. The

  • doctors use simple equipment that requires little

  • maintenance.

  • They also employ a special surgical technique.

  • The main difference is that I remove the clouded lens

  • using what's called the fishhook technique. I use a

  • sort of fishhook that I make myself, out of a syringe. Now

  • I'll make a tunnel incision through the scleraabout

  • two millimeters from the limbus. It's a self-sealing

  • incision, so no stiches are needed.

  • 15 minutes later, he's reached the lens.

  • Here's the thick, clouded lens. You can see that it's turned a

  • brownish red. Far too clouded for anyone

  • to see through it.

  • Silvain El-Khoury now inserts the artificial lens. It comes

  • from India and costs only a few euros, but it works.

  • I use tweezers to slide it into the same spot where the

  • original lens was. I'll turn it a bit to make sure it's in the

  • right position. And then I'll flush the area out again.

  • An antibiotic ointment prevents infection. 25 minutes

  • later, the surgery is done.

  • The procedure went very well, with no complications.

  • The next day, Silvain El-Khoury examines the patient. The

  • doctor carefully removes the bandage.

  • Ask her: Does she see my hand moving?” “Yes.”

  • How many fingers am I showing?” “Two.”

  • Now?” “Five.”

  • The results look good. Next comes a vision test.

  • The surgery was a success. Philamene Nyirami can see

  • even the smallest symbols at the bottom of the chart.

  • I'm very happy to be able to see the people around me,

  • everything around me, I'm very happy.

  • This very gratifying, of course. It reaffirms me in my work

  • and in the life I've chosen for myself.

  • For the first time in years, Philamene Nyirami is able to

  • make her own way across the room. She's still a bit hesitant,

  • but thrilled that she can see again. The procedure cost

  • about 30 euros.

  • The world we're working in is much more difficult. We have

  • fewer machines and diagnostic options. The

  • instruments we use are often older ones. So we face a lot of

  • challenges, especially when it comes to surgery. But we

  • have a good team. They really do the legwork for us and

  • make our own work much easier.

  • Two days later, Philamene Nyirami's other eye also has a

  • new lens. She can see again. Assistants from the CBM aid

  • organization drive her and her daughter as far as they can

  • to the end of the paved road.

  • They'll have to make the final stretch home on foot. The day

  • after surgery, the 20- minute walk is a challengebut she

  • has a new life to look forward to.

  • I'm really very proud to see people smiling after a long

  • time without vision. Then after just like ten minutes, five

  • minutes or ? their vision is restored and a lot of persons

  • who is useless becomes again useful for their community,

  • for the society and for the country in general.

  • Her children, grandchildren, and the entire community

  • have gathered to welcome her return. The last years have

  • been hardunable to see, she was isolated from day to day

  • life. The entire village shares in her joy.

  • This is a miracle, that I can see! I am very happy! I'm

  • now celebrating with my children.

  • Philamene Nyirami spent five years waiting for surgery. Now

  • her vision has been restored.

  • In Rwanda and around the world, a lot of progress in

  • treating eye conditions has been made. But new

  • challenges are also emerging. The use of smart phones, for

  • example, is a problem. And as life expectancy rises, eye

  • disorders are also on the rise. But there is hope.

  • Eye surgery will improve. More drug therapies will

  • become available. I think we'll make a lot of progress in

  • preventing the deterioration of vision and

  • the loss of vision in old age.

  • New surgical methods, better artificial corneas, retinal

  • implant microchipsthe future of medical treatment to

  • preserve vision is a promising one.

  • I'm really pleased. I'll have surgery on my other eye, too.

  • Reprogramming stem cells is a great leap forwardbut

  • researchers are convinced that even more

  • progress will be made.

  • In the next few years, we'll see a great deal of potential

  • in the field of gene therapy. We'll also see advances in

  • pharmacological and microsurgical therapies.

Eye conditions are on the rise. From cataracts to near-

Subtitles and vocabulary

Click the word to look it up Click the word to find further inforamtion about it